Bionomics Limited Stock Cash Flow From Operations
| BNOEFDelisted Stock | USD 0.01 0.00 0.00% |
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Cash Flow From Operations Analysis
Bionomics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Bionomics Cash Flow From Operations | (21.76 M) |
Most of Bionomics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Bionomics Limited has (21.76 Million) in Cash Flow From Operations. This is 104.13% lower than that of the Healthcare sector and 134.79% lower than that of the Biotechnology industry. The cash flow from operations for all United States stocks is 102.24% higher than that of the company.
Bionomics Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in cash flow from operations category among its peers.
Bionomics Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (2.91) % | |||
| Current Valuation | 27.83 M | |||
| Shares Outstanding | 1.35 B | |||
| Shares Owned By Insiders | 6.00 % | |||
| Shares Owned By Institutions | 48.96 % | |||
| Price To Earning | (34.09) X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 8.29 X | |||
| Revenue | 263.63 K | |||
| Gross Profit | (9.94 M) | |||
| EBITDA | (21.92 M) | |||
| Net Income | (21.76 M) | |||
| Cash And Equivalents | 33.56 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 693.62 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 12.46 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (21.76 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 22 | |||
| Beta | 2.18 | |||
| Market Capitalization | 29.11 M | |||
| Total Asset | 65.31 M | |||
| Retained Earnings | (103 M) | |||
| Working Capital | 47 M | |||
| Current Asset | 58 M | |||
| Current Liabilities | 11 M | |||
| Z Score | 23.2 | |||
| Net Asset | 65.31 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |